Kazakhstan vs Togo: Previously treated cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
Togo
100.0%
in 2024
Kazakhstan rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Kazakhstan
- Togo
How they compare
Kazakhstan currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 5 times across 17 shared years of data; in 2007 it was Kazakhstan ahead.
Kazakhstan ranks 1st and Togo ranks 1st of 180 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.3% | 12.6% | 36.7% | Kazakhstan |
| 2010s | 91.4% | 61.3% | 30.1% | Kazakhstan |
| 2020s | 100.0% | 92.2% | 7.8% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Kazakhstan or Togo?
- Kazakhstan, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Kazakhstan and Togo?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Togo?
- 17 years are reported by both, from 2007 to 2024.
- How do Kazakhstan and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.